Metis Consulting Services Inc.
Michelleanne Bradley is a seasoned professional in Drug Safety, Pharmacovigilance, Compliance, and Quality Assurance Services, currently serving as President at Metis Consulting Services since October 2016. With a robust background that includes roles such as Director of Drug Safety and Pharmacovigilance at Immune Design and Galena Biopharma, and a Drug Safety Manager at Onyx Pharmaceuticals, Michelleanne has extensive experience in audit readiness, gap analysis, and the development of scalable systems. Prior positions include consulting for Edge Alliance, operations management at Amgen, and various roles in safety and regulatory affairs. Michelleanne holds a BA in Spanish, Women's Studies, and Latin American Studies from The University of Georgia.
This person is not in any teams
This person is not in any offices
Metis Consulting Services Inc.
Metis Consulting Services is a boutique international consultancy serving Biotech and Pharmaceutical Industries. Metis is focused on GxP services, with specialization in Pharmacovigilance, Quality Assurance, Acquisition Integration (M&A), REMS, Scalable Implementation Planning, and Compliance services. We are a woman founded; women run organization. The mission of Metis Consulting Services is to provide the biotech and pharmaceutical industries with strategic solutions to facilitate effective and innovative solutions to meet and exceed worldwide bench to market requirements in established and emerging markets. Patient safety is our primary focus. Our target market is global biotech and pharmaceutical companies. Our industry is ever evolving and growing. We are the decision makers, we are the trusted advisors, we are the cutting edge of how things will be in the future. Contact us at info@metisconsultingservices.com